Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Anti-HCV Next

K-Number: K252424 · 2026-04-28

ApplicantAbbott Laboratories
Decision Date2026-04-28
Product CodeMZO
Advisory CommitteeMI
DecisionSubstantially Equivalent

Device Summary

Anti-HCV Next is the device name listed in this FDA 510(k) record. The listed applicant is Abbott Laboratories. It received FDA 510(k) clearance on 2026-04-28 under 510(k) number K252424. The device is classified under product code MZO. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Anti-HCV Next?

Anti-HCV Next is a medical device that received FDA 510(k) clearance on 2026-04-28. The listed applicant is Abbott Laboratories. The 510(k) number is K252424.

When did Anti-HCV Next receive FDA 510(k) clearance?

Anti-HCV Next received FDA 510(k) clearance on 2026-04-28, under 510(k) number K252424.

Who is the listed applicant for Anti-HCV Next?

The FDA 510(k) record lists Abbott Laboratories as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Anti-HCV Next?

The FDA product code for Anti-HCV Next is MZO.

Other records listing Abbott Laboratories as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

PMA P120008KIT, TEST, ALPHA-FETOPROTEIN FOR NEURAL TUBE DEFECTSPMA P910007Total, prostate specific antigen (noncomplexed & complexed) for detection of prostate cancerPMA P980007Test, prostate specific antigen, free, (noncomplexed) to distinguish prostate cancer from benign conditionsK243500ARCHITECT iGentamicinK243168Alinity i Rubella IgGPMA P210003Test, Hepatitis B (B Antigen, B Surface Antigen, Be Antigen)

View all 36 devices →

Related Devices (Code: MZO)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K221693Elecsys Anti-HCV II (08837031190)Roche DiagnosticsPMA P050042Assay, enzyme linked immunosorbent, hepatitis c virusAbbott Laboratories, Inc.PMA P190011Assay, enzyme linked immunosorbent, hepatitis c virusDiaSorin, Inc.PMA P030056Assay, enzyme linked immunosorbent, hepatitis c virusSiemens Healthcare DiagnosticsPMA P080027Assay, enzyme linked immunosorbent, hepatitis c virusOraSure Technologies, Inc.PMA P010021Assay, enzyme linked immunosorbent, hepatitis c virusOrtho-Clinical Diagnostics, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑